|
Summary:
Ramucirumab, Gilteritinib, Glofitamab 2025 Country:
Czech Republic
Notice Type:
Tender Notice Deadline:
14 Apr 2025 Posting Date:
11 Mar 2025 |
|
Summary:
Elasto -Sculptive Solutions 2025 Country:
Czech Republic
Notice Type:
Tender Notice Deadline:
14 Apr 2025 Posting Date:
11 Mar 2025 |
|
Summary:
Antivirotics 2024 Country:
Czech Republic
Notice Type:
Tender Notice Deadline:
14 Apr 2025 Posting Date:
11 Mar 2025 |
|
Summary:
Medicinal Products For The Therapy Of Cystic Fibrosis 2025-Ii Country:
Czech Republic
Notice Type:
Tender Notice Deadline:
11 Apr 2025 Posting Date:
11 Mar 2025 |
|
Summary:
Medicinal Products With The Active Ingredient Of The Slowdomide Ii Country:
Czech Republic
Notice Type:
Tender Notice Deadline:
11 Apr 2025 Posting Date:
11 Mar 2025 |
|
Summary:
Medicinal Product With The Active Substance Infliximab Reopening Country:
Czech Republic
Notice Type:
Tender Notice Deadline:
30 May 2025 Posting Date:
11 Mar 2025 |
|
Summary:
Medicinal Products For The Therapy Of Cystic Fibrosis 2025 Country:
Czech Republic
Notice Type:
Tender Notice Deadline:
10 Apr 2025 Posting Date:
10 Mar 2025 |
|
Summary:
Examination Of The Blood Count For The Haemato-Oncological Clinic With Borrowing Country:
Czech Republic
Notice Type:
Tender Notice Deadline:
11 Apr 2025 Posting Date:
10 Mar 2025 |
|
Summary:
Medicinal Products With The Active Substance Country:
Czech Republic
Notice Type:
Tender Notice Deadline:
07 Apr 2025 Posting Date:
10 Mar 2025 |
|
Summary:
Medicinal Products Containing Itoprid Hydrochloride And Monohydrate Of Sodium Salts Of Metamisol, Nervousone-Hydrochloride Country:
Czech Republic
Notice Type:
Tender Notice Deadline:
08 Apr 2025 Posting Date:
10 Mar 2025 |
Most trusted source for Tendering Opportunities and Business Intelligence since 2002